Clinical Trial Update: Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) [Phase 4]

View source ↗

Summary

Phase 4 ACUTE II trial evaluating cardioversion using transesophageal echocardiography in atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: The Cleveland Clinic | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED